The OPRM1 gene: The powerhouse of pain killers

Presenter's Name(s)

Nathan Estrella

Abstract

Prior research has identified the OPRM1 gene as a factor in genetic dispositions to addiction. This gene is responsible for the production of mu-opioid receptors, which are used to modulate pain in the nervous system. The authors sought to identify the outcomes of single nucleotide polymorphisms (SNPs) of the OPRM1 gene. They found that the homozygous recessive genotype is less common and that this genotype resulted in a SNP that inhibited OPRM1 function. These findings provide a better understanding of how genetics and addiction tend to influence one another.

Primary Faculty Mentor Name

Melissa Pespeni

Status

Undergraduate

Student College

College of Arts and Sciences

Program/Major

Biology

Primary Research Category

Life Sciences

Abstract only.

Share

COinS
 

The OPRM1 gene: The powerhouse of pain killers

Prior research has identified the OPRM1 gene as a factor in genetic dispositions to addiction. This gene is responsible for the production of mu-opioid receptors, which are used to modulate pain in the nervous system. The authors sought to identify the outcomes of single nucleotide polymorphisms (SNPs) of the OPRM1 gene. They found that the homozygous recessive genotype is less common and that this genotype resulted in a SNP that inhibited OPRM1 function. These findings provide a better understanding of how genetics and addiction tend to influence one another.